Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000262207 | SCV000372093 | uncertain significance | Thrombophilia due to thrombin defect | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV002468939 | SCV000372094 | uncertain significance | Congenital prothrombin deficiency | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002418154 | SCV002678071 | likely benign | Inborn genetic diseases | 2022-09-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003391074 | SCV004130061 | likely benign | not provided | 2022-05-01 | criteria provided, single submitter | clinical testing | F2: BP4, BP7 |
Labcorp Genetics |
RCV002468939 | SCV004272074 | benign | Congenital prothrombin deficiency | 2024-01-31 | criteria provided, single submitter | clinical testing |